A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
Pindolol has been studied across 15 research domains including ❤️ Cardiovascular, 🌤️ Mood & Depression, 🫘 Kidney, 🧠 Focus & Attention, 😴 Sleep. The primary research focus is ❤️ Cardiovascular with 32% of studies addressing this area.
The following compounds share molecular targets with Pindolol, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.
This evidence profile for Pindolol is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.